Big pharma craves slice of AI-based RNA drug discovery

被引：1
|
作者：
机构：
来源：
Nature Biotechnology | 2023年 / 41卷 / 3期
关键词：
D O I：
10.1038/s41587-023-01725-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 305
相关论文
共 50 条
  • [1] AI-based language models powering drug discovery and development
    Liu, Zhichao
    Roberts, Ruth A.
    Lal-Nag, Madhu
    Chen, Xi
    Huang, Ruili
    Tong, Weida
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2593 - 2607
  • [2] AI-based optical materials discovery
    Ghasemi, Amir
    Fang, Rui
    Zeze, DAgou A.
    Keshavarz-Hedayati, Mehdi
    MACHINE LEARNING IN PHOTONICS, 2024, 13017
  • [3] AI-powered drug discovery captures pharma interest
    Smalley, Eric
    NATURE BIOTECHNOLOGY, 2017, 35 (07) : 604 - 605
  • [4] AI-powered drug discovery captures pharma interest
    Eric Smalley
    Nature Biotechnology, 2017, 35 : 604 - 605
  • [5] Why is big Pharma getting out of antibacterial drug discovery?
    Projan, SJ
    CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) : 427 - 430
  • [6] Harnessing the power of AI-based models to accelerate drug discovery against immune diseases
    Moingeon, Philippe
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (10) : 1135 - 1138
  • [7] Medicinal chemistry in drug discovery in big pharma: past, present and future
    Campbell, Ian B.
    Macdonald, Simon J. F.
    Procopiou, Panayiotis A.
    DRUG DISCOVERY TODAY, 2018, 23 (02) : 219 - 234
  • [8] The big and small of drug discovery - Biotech versus pharma: advantages and drawbacks in drug development
    Moore, A
    EMBO REPORTS, 2003, 4 (02) : 114 - 117
  • [9] Transforming cancer drug discovery with Big Data and AI
    Workman, Paul
    Antolin, Albert A.
    Al-Lazikani, Bissan
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (11) : 1089 - 1095
  • [10] Overcoming traditional design limitations with AI-based discovery
    Hallett, David J.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
12345